Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Vera Therapeutics, Inc. (VERA) had Debt to Equity Ratio of 0.09 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-152.15M |
|
-- |
|
-- |
|
$167.17M |
|
$-167.17M |
|
$15.02M |
|
$-152.15M |
|
$-152.15M |
|
$-152.15M |
|
$-152.15M |
|
$-152.15M |
|
$-152.15M |
|
$-167.17M |
|
$-175.23M |
|
55.33M |
|
55.33M |
|
$-2.75 |
|
$-2.75 |
|
| Balance Sheet Financials | |
$651.22M |
|
$0.96M |
|
$4.46M |
|
$655.68M |
|
$25.37M |
|
$50.69M |
|
$53.16M |
|
$78.53M |
|
$577.15M |
|
$577.15M |
|
$577.15M |
|
63.56M |
|
| Cash Flow Statement Financials | |
$-134.68M |
|
$-425.03M |
|
$606.67M |
|
$45.68M |
|
$92.65M |
|
$46.97M |
|
$20.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.67 |
|
-- |
|
-- |
|
0.08 |
|
|
Debt to Equity Ratio |
0.09 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-135.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.36% |
|
-26.36% |
|
-23.20% |
|
-24.23% |
|
$9.08 |
|
$-2.45 |
|
$-2.43 |
|